Stories > EMA Backs Ocugen's Gene Therapy

EMA Backs Ocugen's Gene Therapy

4D Molecular Therapeutics Raises $300 Mi...

4DMT Presents Positive Interim Data

Advancements in Cancer Treatment and Mar...

Biopharma Innovator GeNeuro Discloses Pr...

Genomic Tech's Investment Potential

Innovative GI Drug Data Revealed